Frequency of relapse and persistent cutaneous symptoms after a first episode of chilblain-like lesion during the COVID-19 pandemic.

Moghadam, P; Frumholtz, L; Jaume, L; De Masson, A; Jachiet, M; Begon, E; Sulimovic, L; Petit, A; Bachelez, H; Bagot, M; Bouaziz, J-D; Cassius, C

Moghadam, P; Frumholtz, L; Jaume, L; De Masson, A; Jachiet, M; Begon, E; Sulimovic, L; Petit, A; Bachelez, H; Bagot, M; Bouaziz, J-D; Cassius, C.

Afiliação

Moghadam P; Dermatology Department, AP-HP, Saint-Louis Hospital, Paris, France.
Frumholtz L; Dermatology Department, AP-HP, Saint-Louis Hospital, Paris, France.
Jaume L; Dermatology Department, AP-HP, Saint-Louis Hospital, Paris, France.
De Masson A; Dermatology Department, AP-HP, Saint-Louis Hospital, Paris, France.
Jachiet M; Université de Paris, Human immunology Pathophysiology Immunotherapy, INSERM U976, Institut de Recherche Saint-Louis, Paris, France.
Begon E; Dermatology Department, AP-HP, Saint-Louis Hospital, Paris, France.
Sulimovic L; Dermatology Department, AP-HP, Saint-Louis Hospital, Paris, France.
Petit A; Dermatology Department, Renée Dubos Hospital, Pontoise, France.
Bachelez H; Dermatology Department, AP-HP, Saint-Louis Hospital, Paris, France.
Bagot M; On behalf of the SNDV (syndicat national des dermatologues-vénéréologues) /Corona group, Paris, France.
Bouaziz JD; Dermatology Department, AP-HP, Saint-Louis Hospital, Paris, France.
Cassius C; Dermatology Department, AP-HP, Saint-Louis Hospital, Paris, France.

J Eur Acad Dermatol Venereol ; 35(9): e566-e568, 2021 09.

Article em En | MEDLINE | ID: mdl-34036642

Assuntos

COVID-19; Pérnio; Pérnio/diagnóstico; Pérnio/epidemiologia; Humanos; Pandemias; Recidiva; SARS-CoV-2

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Pérnio / COVID-19 Tipo de estudo: Diagnostic_studies / Prognostic_studies Limite: Humans Idioma: En Ano de publicação: 2021 Tipo de documento: Article

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google